$RGBP The enzyme silenced is Indoleamine 2,3-dioxygenase (IDO) , an enzyme that is overexpressed in some cancers and which suppresses immune system response against the cancer. The Company believes it has supplied the additional data and clarifications the FDA requested.
https://finance.yahoo.com/news/regen-biopharm...00789.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!